https://www.valohealth.com | United States | 2019 | $400M
Valo Health is a drug discovery technology company based in the United States. It was founded and initially capitalized by Flagship Pioneering in 2019 and has received additional funding, totaling nearly $100 million. Valo Health has developed the Opal Computational Platform™, integrating machine learning and data to accelerate drug discovery, reduce surrogate dependency, and enable insights across preclinical and clinical studies. The company focuses on neurodegenerative and oncology diseases, aiming to drive therapeutic success through technology.
